QuickMedical has announced the US launch of complete line of WaveSense blood glucose monitoring systems for detecting accurate blood glucose readings.
The current use of glucose dehydrogenase pyrroloquinoline quinone (GDH PQQ) enzyme in the strips of many glucose meters may give a false-elevated blood glucose reading, according to the company.
QuickMedical reported that all WaveSense-branded blood glucose meters using glucose oxidase (GOD) enzyme were tested at levels of maltose that exceeded clinical relevance (120mg/dl, 6.7mmol/L) and were shown to have no effect on the glucose reading at that level.
The WaveSense test strips were also tested at high concentrations of galactose (15mg/dl, 0.84 mmol/L) and were shown to have no effect on blood glucose readings at that level.
QuickMedical marketing director Loren Timmons said the company elected to distribute the WaveSense meters over other brands because the meters are more accurate.
"Several blood glucose monitoring systems on the market may provide artificially high readings in certain patients due to particular test strip chemistry, but the WaveSense System uses a different chemistry and technology so it is not susceptible to these artificially high settings," Timmons added.
